Clinical and MRI features associated with amyloid positivity in secondary screening for anti-amyloid-β therapy.

Yamada K, Kurihara M, Akitomi Y, Sato K, Shimasaki R, Hatano K, Bannai T, Suzuki F, Furuta K, Tokumaru AM, Ishii K, Ihara R, Iwata A.

Open source

DOI
10.1002/dad2.70374
Published
2026-04-01
Container
Alzheimers Dement (Amst)
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/dad2.70374,
  title = {Clinical and MRI features associated with amyloid positivity in secondary screening for anti-amyloid-β therapy.},
  author = {Yamada K and  Kurihara M and  Akitomi Y and  Sato K and  Shimasaki R and  Hatano K and  Bannai T and  Suzuki F and  Furuta K and  Tokumaru AM and  Ishii K and  Ihara R and  Iwata A.},
  year = {2026},
  journal = {Alzheimers Dement (Amst)},
  doi = {10.1002/dad2.70374},
  url = {https://doi.org/10.1002/dad2.70374}
}

RIS

TY  - JOUR
TI  - Clinical and MRI features associated with amyloid positivity in secondary screening for anti-amyloid-β therapy.
AU  - Yamada K
AU  -  Kurihara M
AU  -  Akitomi Y
AU  -  Sato K
AU  -  Shimasaki R
AU  -  Hatano K
AU  -  Bannai T
AU  -  Suzuki F
AU  -  Furuta K
AU  -  Tokumaru AM
AU  -  Ishii K
AU  -  Ihara R
AU  -  Iwata A.
PY  - 2026
JO  - Alzheimers Dement (Amst)
DO  - 10.1002/dad2.70374
UR  - https://doi.org/10.1002/dad2.70374
ER  - 

APA

K, Y., M, K., Y, A., K, S., R, S., K, H., T, B., F, S., K, F., AM, T., K, I., R, I., & A., I. (2026). Clinical and MRI features associated with amyloid positivity in secondary screening for anti-amyloid-β therapy.. Alzheimers Dement (Amst). https://doi.org/10.1002/dad2.70374

Source records